270 related articles for article (PubMed ID: 19034960)
1. Interaction of major genes predisposing to hepatocellular carcinoma with genes encoding signal transduction pathways influences tumor phenotype and prognosis.
Feo F; Frau M; Pascale RM
World J Gastroenterol; 2008 Nov; 14(43):6601-15. PubMed ID: 19034960
[TBL] [Abstract][Full Text] [Related]
2. Genetic and epigenetic control of molecular alterations in hepatocellular carcinoma.
Feo F; Frau M; Tomasi ML; Brozzetti S; Pascale RM
Exp Biol Med (Maywood); 2009 Jul; 234(7):726-36. PubMed ID: 19429855
[TBL] [Abstract][Full Text] [Related]
3. Aberrant iNOS signaling is under genetic control in rodent liver cancer and potentially prognostic for the human disease.
Calvisi DF; Pinna F; Ladu S; Pellegrino R; Muroni MR; Simile MM; Frau M; Tomasi ML; De Miglio MR; Seddaiu MA; Daino L; Sanna V; Feo F; Pascale RM
Carcinogenesis; 2008 Aug; 29(8):1639-47. PubMed ID: 18579559
[TBL] [Abstract][Full Text] [Related]
4. Forkhead box M1B is a determinant of rat susceptibility to hepatocarcinogenesis and sustains ERK activity in human HCC.
Calvisi DF; Pinna F; Ladu S; Pellegrino R; Simile MM; Frau M; De Miglio MR; Tomasi ML; Sanna V; Muroni MR; Feo F; Pascale RM
Gut; 2009 May; 58(5):679-87. PubMed ID: 19136513
[TBL] [Abstract][Full Text] [Related]
5. Pleiotropic effects of methionine adenosyltransferases deregulation as determinants of liver cancer progression and prognosis.
Frau M; Feo F; Pascale RM
J Hepatol; 2013 Oct; 59(4):830-41. PubMed ID: 23665184
[TBL] [Abstract][Full Text] [Related]
6. Ras-driven proliferation and apoptosis signaling during rat liver carcinogenesis is under genetic control.
Calvisi DF; Pinna F; Pellegrino R; Sanna V; Sini M; Daino L; Simile MM; De Miglio MR; Frau M; Tomasi ML; Seddaiu MA; Muroni MR; Feo F; Pascale RM
Int J Cancer; 2008 Nov; 123(9):2057-64. PubMed ID: 18697198
[TBL] [Abstract][Full Text] [Related]
7. Mybl2 expression is under genetic control and contributes to determine a hepatocellular carcinoma susceptible phenotype.
Frau M; Ladu S; Calvisi DF; Simile MM; Bonelli P; Daino L; Tomasi ML; Seddaiu MA; Feo F; Pascale RM
J Hepatol; 2011 Jul; 55(1):111-9. PubMed ID: 21419759
[TBL] [Abstract][Full Text] [Related]
8. Role of transcriptional and posttranscriptional regulation of methionine adenosyltransferases in liver cancer progression.
Frau M; Tomasi ML; Simile MM; Demartis MI; Salis F; Latte G; Calvisi DF; Seddaiu MA; Daino L; Feo CF; Brozzetti S; Solinas G; Yamashita S; Ushijima T; Feo F; Pascale RM
Hepatology; 2012 Jul; 56(1):165-75. PubMed ID: 22318685
[TBL] [Abstract][Full Text] [Related]
9. Dual-specificity phosphatase 1 ubiquitination in extracellular signal-regulated kinase-mediated control of growth in human hepatocellular carcinoma.
Calvisi DF; Pinna F; Meloni F; Ladu S; Pellegrino R; Sini M; Daino L; Simile MM; De Miglio MR; Virdis P; Frau M; Tomasi ML; Seddaiu MA; Muroni MR; Feo F; Pascale RM
Cancer Res; 2008 Jun; 68(11):4192-200. PubMed ID: 18519678
[TBL] [Abstract][Full Text] [Related]
10. Genetic Predisposition to Hepatocellular Carcinoma.
Pascale RM; Calvisi DF; Feo F; Simile MM
Metabolites; 2022 Dec; 13(1):. PubMed ID: 36676960
[TBL] [Abstract][Full Text] [Related]
11. The degradation of cell cycle regulators by SKP2/CKS1 ubiquitin ligase is genetically controlled in rodent liver cancer and contributes to determine the susceptibility to the disease.
Calvisi DF; Pinna F; Ladu S; Muroni MR; Frau M; Demartis I; Tomasi ML; Sini M; Simile MM; Seddaiu MA; Feo F; Pascale RM
Int J Cancer; 2010 Mar; 126(5):1275-81. PubMed ID: 19533683
[TBL] [Abstract][Full Text] [Related]
12. SKP2 and CKS1 promote degradation of cell cycle regulators and are associated with hepatocellular carcinoma prognosis.
Calvisi DF; Ladu S; Pinna F; Frau M; Tomasi ML; Sini M; Simile MM; Bonelli P; Muroni MR; Seddaiu MA; Lim DS; Feo F; Pascale RM
Gastroenterology; 2009 Nov; 137(5):1816-26.e1-10. PubMed ID: 19686743
[TBL] [Abstract][Full Text] [Related]
13. Altered methionine metabolism and global DNA methylation in liver cancer: relationship with genomic instability and prognosis.
Calvisi DF; Simile MM; Ladu S; Pellegrino R; De Murtas V; Pinna F; Tomasi ML; Frau M; Virdis P; De Miglio MR; Muroni MR; Pascale RM; Feo F
Int J Cancer; 2007 Dec; 121(11):2410-20. PubMed ID: 17680562
[TBL] [Abstract][Full Text] [Related]
14. Cell cycle deregulation in liver lesions of rats with and without genetic predisposition to hepatocarcinogenesis.
Pascale RM; Simile MM; De Miglio MR; Muroni MR; Calvisi DF; Asara G; Casabona D; Frau M; Seddaiu MA; Feo F
Hepatology; 2002 Jun; 35(6):1341-50. PubMed ID: 12029619
[TBL] [Abstract][Full Text] [Related]
15. Hepatocellular carcinoma as a complex polygenic disease. Interpretive analysis of recent developments on genetic predisposition.
Feo F; De Miglio MR; Simile MM; Muroni MR; Calvisi DF; Frau M; Pascale RM
Biochim Biophys Acta; 2006 Apr; 1765(2):126-47. PubMed ID: 16216419
[TBL] [Abstract][Full Text] [Related]
16. An expression signature of phenotypic resistance to hepatocellular carcinoma identified by cross-species gene expression analysis.
Frau M; Simile MM; Tomasi ML; Demartis MI; Daino L; Seddaiu MA; Brozzetti S; Feo CF; Massarelli G; Solinas G; Feo F; Lee JS; Pascale RM
Cell Oncol (Dordr); 2012 Jun; 35(3):163-73. PubMed ID: 22434528
[TBL] [Abstract][Full Text] [Related]
17. Prognostic markers and putative therapeutic targets for hepatocellular carcinoma.
Frau M; Biasi F; Feo F; Pascale RM
Mol Aspects Med; 2010 Apr; 31(2):179-93. PubMed ID: 20176048
[TBL] [Abstract][Full Text] [Related]
18. Peroxiredoxin II promotes hepatic tumorigenesis through cooperation with Ras/Forkhead box M1 signaling pathway.
Park YH; Kim SU; Kwon TH; Kim JM; Song IS; Shin HJ; Lee BK; Bang DH; Lee SJ; Lee DS; Chang KT; Kim BY; Yu DY
Oncogene; 2016 Jul; 35(27):3503-13. PubMed ID: 26500057
[TBL] [Abstract][Full Text] [Related]
19. Mig-6 is down-regulated in HCC and inhibits the proliferation of HCC cells via the P-ERK/Cyclin D1 pathway.
Li Z; Qu L; Luo W; Tian Y; Zhai H; Xu K; Zhong H
Exp Mol Pathol; 2017 Jun; 102(3):492-499. PubMed ID: 28506767
[TBL] [Abstract][Full Text] [Related]
20. Role of HSP90, CDC37, and CRM1 as modulators of P16(INK4A) activity in rat liver carcinogenesis and human liver cancer.
Pascale RM; Simile MM; Calvisi DF; Frau M; Muroni MR; Seddaiu MA; Daino L; Muntoni MD; De Miglio MR; Thorgeirsson SS; Feo F
Hepatology; 2005 Dec; 42(6):1310-9. PubMed ID: 16317707
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
